Otosclerosis and measles virus - Association or causation?

ORL

Volumn 70, Issue 1, 2008, Pages 63-69

  Niedermeyer, H P ^a   Arnold, W ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Epidemiology; Etiopathogenesis; Measles virus; Otosclerosis; Vaccination

Indexed keywords

COLLAGEN; MEASLES VACCINE; RNA; VIRUS PROTEIN;

COLLAGEN 1A1 GENE; COLLAGEN 1A2 GENE; CONDUCTION DEAFNESS; CORRELATION ANALYSIS; GENE; GENE MUTATION; HEALTH PROGRAM; HEALTH SURVEY; HUMAN; IMMUNOREACTIVITY; INFLAMMATION; MEASLES; MEASLES VIRUS; MORPHOLOGY; OSSIFICATION; OSTEOLYSIS; OTOSCLEROSIS; PANENCEPHALITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; STAPES SURGERY; TEMPORAL BONE; TIME SERIES ANALYSIS; VACCINATION; VIRUS INFECTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; OTOSCLEROSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RNA, VIRAL; TEMPORAL BONE; VACCINATION;

EID: 38849191694     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000111049     Document Type: Review

References (50)

1. Valsalva A: De Aurae Humana Tractatus. Venetiis, Johannes Baptista Morgaganus, 1740.
2. Toynbee J: Diseases of the ear. Trans Pathol Soc (Lond) 1853;4:257-259.
3. von Tröltsch A: Treatise on the Diseases of The Ear Including the Anatomy of the Organ. New York, William Wood, 1869.
4. Politzer A: Über primäre Erkrankung der knöchernen Labyrinthkapsel. Z Ohrenheilkd 1894;25:309-327.
5. Siebenmann F: Demonstration mikroskopischer Präparate von Otospongiosis. Proc Int Otol Congr 1912;9:207.
6. Nager FR: Labyrinth malformations in the light of present-day genetics. Pract Otorhinolaryngol (Basel) 1951;13:129.
7. Ogilvie RF, Hall IS: Observation on the pathology of otosclerosis. J Laryngol Otol 1953;67:497-535.
8. Morrison AW: Otosclerosis: a synopsis of natural history and management. BMJ 1970;1:345-348.
9. Guild SR: Histologic otosclerosis. Ann Otol Rhinol Laryngol 1944;53:246-266.
10. Hueb MM, Goycoolea MV, Paparella MM, Oliveira JA: Otosclerosis: the University of Minnesota temporal bone collection. Otolaryngol Head Neck Surg 1991;105:396-405.
11. Soifer NK, Weaver GI, Endahl GL, Holdsworth GE Jr: Otosclerosis: a review. Acta Otolaryngol Suppl 1970;269:1-25.
12. Declau F, Van Spaendonck M, Timmermans JP, Michaels L, Liang J, Qiu JP, Van de Heyning P: Prevalence of otosclerosis in an unselected series of temporal bones. Otol Neurotol 2001;22:596-602.
13. Yagi T: Incidence and characteristics of otosclerosis in the Japanese population. Auris Nasus Larynx 2002;29:257-260.
14. Gordon MA: The genetics of otosclerosis: a review. Am J Otol 1989;10:426-438.
15. Van Den Bogaert K, De Leenheer EM, Chen W, Lee Y, Nurnberg P, Pennings RJ, Vanderstraeten K, Thys M, Cremers CW, Smith RJ, Van Camp G: A fifth locus for otosclerosis, OTSC5, maps to chromosome 3q22-24. J Med Genet 2004;41:450-453.
16. Rodriguez L, Rodriguez S, Hermida J, Frade C, Sande E, Visedo G, Martin C, Zapata C: Proposed association between the COL1A1 and COL1A2 genes and otosclerosis is not supported by a case-control study in Spain. Am J Med Genet A 2004;128:19-22.
17. Arnold W, Friedmann I: Otosclerosis - an inflammatory disease of the otic capsule of viral aetiology? J Laryngol Otol 1988;102:865-871.
18. Arnold W, Friedmann I: Immunohistochemistry of otosclerosis. Acta Otolaryngol Suppl 1990;470:124-129; discussion 128-129.
19. Altermatt HJ, Gerber HA, Gaeng D, Müller C, Arnold W: Immunohistochemical findings in otosclerotic lesions. HNO 1992;40:476-479.
20. Karosi T, Konja J, Szabo LZ, Pytel J, Jori J, Szamlmas A, Sziklai I: Codetection of measles virus and tumor necrosis factor-alpha mRNA in otosclerotic stapes footplates. Laryngoscope 2005;115:1291-1297.
21. Mayer O: Otosclerosis. Zentralbl Hals Nasen Ohrenheilkd 1930;18:628.
22. Sercer A, Krmpotic J: Über die Ursache der progressiven Altersschwerhörigkeit. Acta Otolaryngol Suppl 1958;143:5.
23. Ogilvie RF, Hall IS: On the etiology of otosclerosis. J Laryngol Otol 1962;76:841.
24. Arnold W, Plester D: Vascular degeneration in otosclerosis and its influence on the mesenchymal reaction of the mucoperiosteum. Arch Otol Rhinol Laryngol 1975;209:127-143.
25. Arnold W, Plester D: Active otosclerosis of the stapes footplate: histological and clinical aspects and its influence on the perilymph. Arch Otorhinolaryngol 1977;215:159-178.
26. Wright I: Avascular necrosis of bone and its relation to fixation of an small joint: the pathology and aetiology of 'otosclerosis'. J Pathol 1977;123:5-25.
27. Causse J, Chevance LG, Bel J: L'otospongiose: maladie enzymatique cellulaire et lysosomale. Confrontation cytoclinique. Ann Otol Laryngol (Paris) 1972;89:563-595.
28. Grayeli AB, Escoubet B, Bichara M, Julien N, Silve C, Friedlander G, Sterkers O, Ferrary E: Increased activity of the diastrophic dysplasia sulfate transporter in otosclerosis and its inhibition by sodium fluoride. Otol Neurotol 2003;24:854-862.
29. Mills BG, Singer FR: Nuclear inclusions in Paget's disease of bone. Science 1976;194:201-202.
30. McKenna MJ, Mills BG, Galey FR, Linthicum FJ: Filamentous structures morphologically similar to viral nucleocapsids in otosclerotic lesions in two patients. Am J Otol 1986;7:25-28.
31. Arnold W, Friedmann I: Presence of virus-specific antigens (Measles, Rubella) around the active otosclerotic focus. Arch Oto Rhino Laryngol 1987;66:167-171.
32. McKenna MJ, Mills BG: Immunohistochemical evidence of measles virus antigens in active otosclerosis. Otolaryngol Head Neck Surg. 1989;101:415-421.
33. Niedermeyer H, Arnold W, Neubert WJ, Höfler H: Evidence of measles virus RNA in otosclerotic tissue. ORL J Otorhinolaryngol Relat Spec 1994;56:130-132.
34. McKenna MJ, Kristiansen AG, Haines J: Polymerase chain reaction amplification of a measles virus sequence from human temporal bone sections with active otosclerosis. Am J Otol 1996;17:827-830.
35. Bozorg Grayeli A, Palmer P, Tran Ba Huy P, Soudant J, Sterkers O, Lebon P, Ferrary E: No evidence of measles virus in stapes samples from patients with otosclerosis. J Clin Microbiol 2000;38:2655-2660.
36. Karosi T, Konya J, Petko M, Szabo LZ, Pytel J, Jori J, Sziklai I: Two subgroups of stapes fixation: otosclerosis and pseudo-otosclerosis. Laryngoscope 2005;115:1968-1973.
37. Arnold W, Niedermeyer HP, Lehn N, Neubert W, Höfler H: Measles virus in otosclerosis and the specific immune response of the inner ear. Acta Otolaryngol (Stockh) 1996;116:705-709.
38. Lolov S, Zarzalanova P, Edrev G, Kyurkchiev S: Decreased measles virus-neutralizing activity in sera from otosclerotic patients. ORL J Otorhinolaryngol Relat Spec 2003;65:279-283.
39. Karosi T, Konya J, Petko M, Szabo LZ, Pytel J, Jori J, Sziklai I: Antimeasles immunoglobulin g for serologic diagnosis of otosclerotic hearing loss. Laryngoscope 2006;116:488-493.
40. Garenne M: Sex differences in measles mortality: a world review. Int J Epidermiol 1994;23:632-642.
41. Rima BK, Baczko K, Clarke DK, Curran MD, Martin SJ, Billeter MA, ter Meulen V: Characterization of clones for the sixth (L) gene and transcriptional map for morbilliviruses. J Gen Virol 1986;67:1971-1978.
42. Billeter MA, Cattaneo R: Molecular biology of defective measles viruses persisting in the human central nervous system; in Kingsbury DW (ed): The Paramyxoviruses. New York, Plenum, 1991, pp 323-345.
43. Reddy SV, Singer FR, Roodman GD: Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 1995;80:2108-2111.
44. Hill B: Environment and disease: association or causation? Proc Roy Soc Med 1965;58:295-300.
45. Niedermeyer HP, Arnold W, Schwub D, Busch R, Wiest I, Sedlmeier R: Shift of the distribution of age in patients with otosclerosis. Acta Otolaryngol 2001;121:197-199.
46. Vrabec JT, Coker NJ: Stapes surgery in the United States. Otol Neurotol 2004;25:465-469.
47. Arnold W, Busch R, Arnold A, Ritscher B, Neiss A, Niedermeyer HP: The influence of measles vaccination on the incidence of otosclerosis in Germany. Eur Arch Otorhinolaryngol 2007, Epub ahead of print.
48. Aaby P, Jensen H, Samb B, Cisse B, Sodemann M, Jakobsen M, Poulsen A, Rodrigues A, Lisse IM, Simondon F, Whittle H: Differences in female-male mortality after high-titre measles vaccine and association with subsequent vaccination with diphtheria-tetanus-pertussis and inactivated polio virus: reanalysis of West-African studies. Lancet 2003;361:2183-2188.
49. Paunio M, Hedman K, Davidkin I, Valle M, Heinonen OP, Leinikki P, Salmi A, Peltola H: Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol Infect 2000;124:263-271.
50. Williams BG, Cutts FT, Dye C: Measles vaccination policy. Epidemiol Infect 1995;115:603-621.